{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T15:41:36Z","timestamp":1781624496172,"version":"3.54.5"},"reference-count":33,"publisher":"Elsevier BV","issue":"30","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Nature Science Foundation of China","doi-asserted-by":"crossref","award":["31100652"],"award-info":[{"award-number":["31100652"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Nature Science Foundation of China","doi-asserted-by":"crossref","award":["81471906"],"award-info":[{"award-number":["81471906"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Nature Science Foundation of China","doi-asserted-by":"crossref","award":["81472815"],"award-info":[{"award-number":["81472815"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Nature Science Foundation of China","doi-asserted-by":"crossref","award":["31600113"],"award-info":[{"award-number":["31600113"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Nature Science Foundation of Jiangsu Province","award":["BK20160462"],"award-info":[{"award-number":["BK20160462"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.vaccine.2018.06.006","type":"journal-article","created":{"date-parts":[[2018,6,19]],"date-time":"2018-06-19T00:11:04Z","timestamp":1529367064000},"page":"4532-4539","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Design and immune characterization of a novel Neisseria gonorrhoeae DNA vaccine using bacterial ghosts as vector and adjuvant"],"prefix":"10.1016","volume":"36","author":[{"given":"Hongmei","family":"Jiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianyun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiankun","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinyan","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guimei","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guocai","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2018.06.006_b0005","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/j.vaccine.2013.08.067","article-title":"Vaccines against gonorrhea: current status and future challenges","volume":"32","author":"Jerse","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.06.006_b0010","series-title":"Global action plan: to control the spread and impact of antimicrobial resistance to Neisseria gonorrhoeae","author":"WHO","year":"2012"},{"key":"10.1016\/j.vaccine.2018.06.006_b0015","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2174\/157016212800618138","article-title":"Modulation of HIV transmission by Neisseria gonorrhoeae: molecular and immunological aspects","volume":"10","author":"Jarvis","year":"2012","journal-title":"Curr HIV Res"},{"key":"10.1016\/j.vaccine.2018.06.006_b0020","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/sti.75.1.3","article-title":"From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection","volume":"75","author":"Fleming","year":"1999","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.vaccine.2018.06.006_b0025","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.clindermatol.2013.08.010","article-title":"Gonorrhea: new challenges","volume":"32","author":"Skerlev","year":"2014","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.vaccine.2018.06.006_b0030","doi-asserted-by":"crossref","first-page":"4520","DOI":"10.1016\/j.vaccine.2015.07.015","article-title":"The potential impact of vaccination on the prevalence of gonorrhea","volume":"33","author":"Craig","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.06.006_b0035","doi-asserted-by":"crossref","first-page":"3416","DOI":"10.4049\/jimmunol.1102746","article-title":"Properdin is critical for antibody-dependent bactericidal activity against Neisseria gonorrhoeae that recruit C4b-binding protein","volume":"188","author":"Gulati","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2018.06.006_b0040","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1365-2958.2005.04838.x","article-title":"The frequency and rate of pilin antigenic variation in Neisseria gonorrhoeae","volume":"58","author":"Criss","year":"2005","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2018.06.006_b0045","doi-asserted-by":"crossref","first-page":"3945","DOI":"10.1128\/IAI.73.7.3945-3953.2005","article-title":"Intranasal administration of recombinant Neisseria gonorrhoeae transferrin binding proteins A and B conjugated to the cholera toxin B subunit induces systemic and vaginal antibodies in mice","volume":"73","author":"Price","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2018.06.006_b0050","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3389\/fmicb.2011.00123","article-title":"experimental gonococcal infection in male volunteers: cumulative experience with Neisseria gonorrhoeae strains FA1090 and MS11mkC","volume":"2","author":"Hobbs","year":"2011","journal-title":"Front Microbiol"},{"key":"10.1016\/j.vaccine.2018.06.006_b0055","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13567-017-0442-5","article-title":"Bacterial ghosts as adjuvants: mechanisms and potential","volume":"48","author":"Hajam","year":"2017","journal-title":"Vet Res"},{"key":"10.1016\/j.vaccine.2018.06.006_b0060","doi-asserted-by":"crossref","first-page":"5760","DOI":"10.1016\/j.vaccine.2010.06.087","article-title":"Bacterial ghosts (BGs)\u2013advanced antigen and drug delivery system","volume":"28","author":"Kudela","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.06.006_b0065","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.copbio.2004.10.004","article-title":"Bacterial ghosts\u2013biological particles as delivery systems for antigens, nucleic acids and drugs","volume":"15","author":"Tabrizi","year":"2004","journal-title":"Curr Opin Biotechnol"},{"key":"10.1016\/j.vaccine.2018.06.006_b0070","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.mimet.2010.07.001","article-title":"Helicobacter pylori bacterial ghost containing recombinant Omp18 as a putative vaccine","volume":"82","author":"Talebkhan","year":"2010","journal-title":"J Microbiol Methods"},{"key":"10.1016\/j.vaccine.2018.06.006_b0075","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ymthe.2004.09.024","article-title":"DNA-loaded bacterial ghosts efficiently mediate reporter gene transfer and expression in macrophages","volume":"11","author":"Paukner","year":"2005","journal-title":"Mol Ther"},{"key":"10.1016\/j.vaccine.2018.06.006_b0080","article-title":"Antibodies with higher bactericidal activity induced by a Neisseria gonorrhoeae Rmp deletion mutant strain","volume":"9","author":"Li","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2018.06.006_b0085","doi-asserted-by":"crossref","first-page":"4321","DOI":"10.1128\/JCM.43.9.4321-4327.2005","article-title":"Cultivation of Neisseria gonorrhoeae in liquid media and determination of its in vitro susceptibilities to quinolones","volume":"43","author":"Takei","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2018.06.006_b0090","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1128\/CVI.05245-11","article-title":"Neisseria gonorrhoeae NspA induces specific bactericidal and opsonic antibodies in mice","volume":"18","author":"Li","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2018.06.006_b0095","doi-asserted-by":"crossref","DOI":"10.1093\/femsle\/fnw239","article-title":"The enhanced immune responses induced by Salmonella enteritidis ghosts loaded with Neisseria gonorrhoeae porB against Salmonella in mice","volume":"363","author":"Jiao","year":"2016","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.vaccine.2018.06.006_b0100","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.canlet.2007.11.031","article-title":"Effective gene transfer to melanoma cells using bacterial ghosts","volume":"262","author":"Kudela","year":"2008","journal-title":"Cancer Lett"},{"key":"10.1016\/j.vaccine.2018.06.006_b0105","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.mimet.2015.11.009","article-title":"Construction of bacterial ghosts for transfer and expression of a chimeric hepatitis C virus gene in macrophages","volume":"119","author":"Miri","year":"2015","journal-title":"J Microbiol Methods"},{"key":"10.1016\/j.vaccine.2018.06.006_b0110","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1189\/jlb.4A0616-270R","article-title":"Rationalized design of a mucosal vaccine protects against Mycobacterium tuberculosis challenge in mice","volume":"101","author":"Ahmed","year":"2017","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.vaccine.2018.06.006_b0115","doi-asserted-by":"crossref","first-page":"5600","DOI":"10.1016\/j.vaccine.2014.07.106","article-title":"Studies on recombinant glucokinase (r-glk) protein of Brucella abortus as a candidate vaccine molecule for brucellosis","volume":"32","author":"Vrushabhendrappa","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.06.006_b0120","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.vaccine.2005.07.065","article-title":"Characterization of a peptide vaccine candidate mimicking an oligosaccharide epitope of Neisseria gonorrhoeae and resultant immune responses and function","volume":"24","author":"Ngampasutadol","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.06.006_b0125","doi-asserted-by":"crossref","first-page":"e235","DOI":"10.1016\/S1473-3099(17)30310-9","article-title":"Sexually transmitted infections: challenges ahead","volume":"17","author":"Unemo","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2018.06.006_b0130","doi-asserted-by":"crossref","first-page":"7558","DOI":"10.1128\/IAI.73.11.7558-7568.2005","article-title":"Comparison of immune responses to Gonococcal PorB delivered as outer membrane vesicles, recombinant protein, or venezuelan equine encephalitis virus replicon particles","volume":"73","author":"Zhu","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2018.06.006_b0135","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ijmm.2004.04.003","article-title":"Recombinant bacterial ghosts: versatile targeting vehicles and promising vaccine candidates","volume":"294","author":"Hoffelner","year":"2004","journal-title":"Int J Med Microbiol"},{"key":"10.1016\/j.vaccine.2018.06.006_b0140","doi-asserted-by":"crossref","first-page":"6858","DOI":"10.4049\/jimmunol.172.11.6858","article-title":"Bacterial ghosts are an efficient delivery system for DNA vaccines","volume":"172","author":"Ebensen","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2018.06.006_b0145","doi-asserted-by":"crossref","first-page":"6335","DOI":"10.1016\/j.vaccine.2016.10.066","article-title":"Multifaceted immune responses and protective efficacy elicited by a recombinant autolyzed Salmonella expressing FliC flagellar antigen of F18+ Escherichia coli","volume":"34","author":"Won","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.06.006_b0150","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/j.addr.2005.01.027","article-title":"Bacterial ghosts as antigen delivery vehicles","volume":"57","author":"Mayr","year":"2005","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.vaccine.2018.06.006_b0155","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1515\/BC.2008.054","article-title":"Dendritic cell subtypes as primary targets of vaccines: the emerging role and cross-talk of pattern recognition receptors","volume":"389","author":"Benko","year":"2008","journal-title":"Biol Chem"},{"key":"10.1016\/j.vaccine.2018.06.006_b0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0144397","article-title":"Bacterial ghosts of Escherichia coli drive efficient maturation of bovine monocyte-derived dendritic cells","volume":"10","author":"Hajam","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2018.06.006_b0165","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1038\/mi.2017.11","article-title":"Experimental vaccine induces Th1-driven immune responses and resistance to Neisseria gonorrhoeae infection in a murine model","volume":"10","author":"Liu","year":"2017","journal-title":"Mucosal Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1830817X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1830817X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,21]],"date-time":"2018-08-21T06:00:02Z","timestamp":1534831202000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X1830817X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":33,"journal-issue":{"issue":"30","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S0264410X1830817X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.06.006","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design and immune characterization of a novel Neisseria gonorrhoeae DNA vaccine using bacterial ghosts as vector and adjuvant","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.06.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}